Schedule 13G ownership disclosure

Abeona Therapeutics Inc

Common Stock, $0.01 par value · CUSIP: 00289Y206

Event date: 2026-09-30

Filing-level shares
4,159,099.00
Percent of class
7.3%
  • Daniel Kaufman

    Shares: 4,159,099.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001099910-26-000305
Form type
SCHEDULE 13G/A
Filer
Kaufman Daniel Louis
CIK
CIK 2001906
Filed
Nov 12, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub